Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole for depressive symptoms in Parkinson's disease
2005-003788-22Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in Parkinson's disease (PD) comparing Sifrol with Placebo (2 arms). Primary endpoint: Change in Beck Depression Inventory total score. Started Nov 2005; status: completed.
02
Drugs
pramipexole
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-003788-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003788-22.